DOI QR코드

DOI QR Code

Evaluation of Cardiac Functions with Tissue Doppler Imaging in Prediabetic Subjects

  • Kanat, Mustafa (Department of Internal Medicine, Istanbul Medipol University) ;
  • Vardi, Seref (Department of Internal Medicine, Izzet Baysal Medical School, University of Abant Izzet Baysal) ;
  • Arinc, Huseyin (Department of Cardiology, Izzet Baysal Medical School, University of Abant Izzet Baysal) ;
  • Gunduz, Huseyin (Department of Cardiology, Izzet Baysal Medical School, University of Abant Izzet Baysal) ;
  • Erdem, Alim (Department of Cardiology, Izzet Baysal Medical School, University of Abant Izzet Baysal) ;
  • Karagoz, Yalcin (Department of Internal Medicine, Izzet Baysal Medical School, University of Abant Izzet Baysal)
  • Published : 2013.02.28

Abstract

Background and Objectives: The aim of the present study was to evaluate left ventricle systolic and diastolic function, using tissue Doppler echocardiography (TDE), in relation to blood glucose status in prediabetic patients who had no evidence of heart disease by conventional echocardiography (CE). Subjects and Methods: We included 60 patients (30 female, 30 male) and 20 healthy controls (10 male, 10 female). All participants were randomised into four groups according to their oral glucose tolerance test. Group-I consisted of those patients who had only impaired fasting glucose (IFG). group-II consisted of patients who had only impaired glucose tolerance (IGT) and group-III consisted of patients who had both IFG and IGT, that is so-called combined glucose intolerance. Group-IV included the healthy controls. All subjects underwent both CE and TDE. Results: No significant differences were found among the four groups in terms of CE. There was no significant difference between group-IV and group-I with respect to the early peak diastolic velocity (Ea) of medial mitral annulus ($11.65{\pm}0.66$ vs. $9.72{\pm}1.58$, p>0.05), whereas a statistically significant difference was found between group-IV and group-II ($11.65{\pm}0.66$ vs. $9.06{\pm}1.07$, p<0.001) and between group-IV and group-III ($11.65{\pm}0.66$ vs. $9.74{\pm}1.09$, p<0.05). Conclusion: Diastolic myocardial dysfunction in prediabetic patients may be identified by quantitative TDE before the appearance of CE indices of myocardial dysfunction.

Keywords

References

  1. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults: WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 1993;16:157-77. https://doi.org/10.2337/diacare.16.1.157
  2. Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 1991;68:85-9. https://doi.org/10.1016/0002-9149(91)90716-X
  3. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am J Epidemiol 1988; 128:389-401.
  4. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979;241:2035-8. https://doi.org/10.1001/jama.1979.03290450033020
  5. Shindler DM, Kostis JB, Yusuf S, et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 1996;77:1017-20. https://doi.org/10.1016/S0002-9149(97)89163-1
  6. Piccini JP, Klein L, Gheorghiade M, Bonow RO. New insights into diastolic heart failure: role of diabetes mellitus. Am J Med 2004;116(Suppl 5A):S64-75. https://doi.org/10.1016/j.amjmed.2003.10.021
  7. Rodrigues B, Cam MC, McNeill JH. Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mol Cell Cardiol 1995;27: 169-79. https://doi.org/10.1016/S0022-2828(08)80016-8
  8. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004;25:543-67. https://doi.org/10.1210/er.2003-0012
  9. Bell DS. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 1995;18:708-14. https://doi.org/10.2337/diacare.18.5.708
  10. Golfman LS, Takeda N, Dhalla NS. Cardiac membrane Ca(2+)-transport in alloxan-induced diabetes in rats. Diabetes Res Clin Pract 1996;31 (Suppl):S73-7. https://doi.org/10.1016/0168-8227(96)01233-8
  11. Tahiliani AG, McNeill JH. Diabetes-induced abnormalities in the myocardium. Life Sci 1986;38:959-74. https://doi.org/10.1016/0024-3205(86)90229-8
  12. Sutherland GR, Stewart MJ, Groundstroem KW, et al. Color Doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr 1994;7:441-58. https://doi.org/10.1016/S0894-7317(14)80001-1
  13. Dokainish H. Tissue Doppler imaging in the evaluation of left ventricular diastolic function. Curr Opin Cardiol 2004;19:437-41. https://doi.org/10.1097/01.hco.0000131538.55528.8f
  14. Robillon JF, Sadoul JL, Jullien D, Morand P, Freychet P. Abnormalities suggestive of cardiomyopathy in patients with type 2 diabetes of relatively short duration. Diabete Metab 1994;20:473-80.
  15. Astorri E, Fiorina P, Contini GA, et al. Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulindependent diabetic patients. Clin Cardiol 1997;20:536-40. https://doi.org/10.1002/clc.4960200606
  16. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83. https://doi.org/10.1161/01.CIR.58.6.1072
  17. How to diagnose diastolic heart failure: European Study Group on Diastolic Heart Failure. Eur Heart J 1998;19:990-1003. https://doi.org/10.1053/euhj.1998.1057
  18. Garcia-Fernandez MA, Azevedo J, Moreno M, et al. Regional diastolic function in ischaemic heart disease using pulsed wave Doppler tissue imaging. Eur Heart J 1999;20:496-505. https://doi.org/10.1053/euhj.1998.1278
  19. Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 2002;51: 3020-4. https://doi.org/10.2337/diabetes.51.10.3020
  20. Mizushige K, Yao L, Noma T, et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 2000;101: 899-907. https://doi.org/10.1161/01.CIR.101.8.899
  21. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001;24:5-10. https://doi.org/10.2337/diacare.24.1.5
  22. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355: 260-9. https://doi.org/10.1056/NEJMoa051530
  23. Pogátsa G, Bihari-Varga M, Szinay G. Effect of diabetes therapy on the myocardium in experimental diabetes. Acta Diabetol Lat 1979;16: 129-38. https://doi.org/10.1007/BF02581092
  24. Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. J Clin Invest 1990;86:481-8. https://doi.org/10.1172/JCI114734
  25. Regan TJ, Wu CF, Yeh CK, Oldewurtel HA, Haider B. Myocardial composition and function in diabetes: the effects of chronic insulin use. Circ Res 1981;49:1268-77. https://doi.org/10.1161/01.RES.49.6.1268

Cited by

  1. Early reduced myocardial diastolic function in children and adolescents with type 1 diabetes mellitus a population-based study vol.16, pp.None, 2016, https://doi.org/10.1186/s12872-016-0288-1
  2. Prediabetes, heart mechanics, and echocardiography: A narrative review vol.38, pp.2, 2021, https://doi.org/10.1111/echo.14929